von Willebrand Factor (vWF)-directed Antibodies
- Name
- von Willebrand Factor (vWF)-directed Antibodies
- Accession Number
- DBCAT005686
- Description
Not Available
- Drugs
Drug Drug Description Caplacizumab A von Willebrand factor (vWF)-directed antibody fragment used to treat acquired thrombotic thrombocytopenic purpura (aTTP). - Drugs & Drug Targets
Drug Target Type Caplacizumab von Willebrand factor target